Pharming PHAR Institutional Ownership

Updated Oct 11, 2026

Pharming Group N.V. (NASDAQ:PHAR) counted 18 institutional investors among its 13F-reported shareholders for the quarter ended June 30, 2026.

• These investors held 3.20% of Pharming's outstanding shares at the end of Q2 2026, up from 0.12% in Q1 2026.
• The number of holders of Pharming shares rose 500.00% from Q2 2025.
• Of the 18 holders of PHAR in Q2 2026, 12 added to their positions, 5 reduced their stakes and 1 left its position unchanged.
• Altogether, institutional holders owned 2.24Mn PHAR shares at the end of Q2 2026, up 2.16Mn from the prior quarter and up 2.19Mn from a year earlier.
• MAC Alpha Capital Management, LP held the largest position in PHAR at 2.15Mn shares as of June 30, 2026, or 3.06% of shares outstanding.
• Among holders that already owned Pharming, the biggest buyers in Q2 2026 were Citadel Advisors LLC (+1.78K shares), Knoll Capital Management, LLC (+34 shares) and Morgan Stanley (+11 shares).
• On the other side, among holders that kept a position in Pharming, the largest reductions in Q2 2026 came from Silverberg Bernstein Capital Management LLC (-3.2K shares), SmartHarvest Portfolios, LLC (-382 shares), Larson Financial Group LLC (-336 shares), Osaic Holdings, Inc. (-112 shares) and BNP Paribas Financial Markets (-100 shares).
• Per Business Quant data, the 10 largest holders of Pharming at the end of Q2 2026 were MAC Alpha Capital Management, LP (2.15Mn shares), Silverberg Bernstein Capital Management LLC (41.55K shares), Crossmark Global Holdings, Inc. (12.46K shares), Citadel Advisors LLC (11.97K shares), Morgan Stanley (11.5K shares), SmartHarvest Portfolios, LLC (10.41K shares), Knoll Capital Management, LLC (4.09K shares), Silver Grove Financial Group, Inc. (1.07K shares), Nalls Sherbakoff Group, LLC (870 shares) and Global Retirement Partners, LLC (456 shares).